Metabolic Modulation as Treatment in Acute Heart Failure
NCT00449423
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
32
Enrollment
OTHER
Sponsor class
Stopped
due to slow recruitment
Conditions
Acute Heart Failure
Interventions
DRUG:
acipimox
Sponsor
University of Aarhus